MS
Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1626
Local Bounti
LOCL
$48.2M
|
PK
Pamela Kaufman
| $2.18 | $35.75 |
1,540%
upside
| Equal-Weight |
11 Nov ‘22
2 years ago |
|
1627
Ionis Pharmaceuticals
IONS
$10B
|
AG
Andrew Galler
| $62.95 | $56 |
11%
downside
| Overweight |
10 Nov ‘22
2 years ago |
|
1628
Capri Holdings
CPRI
$2.51B
|
KG
Kimberly Greenberger
| $21.11 | $58 |
175%
upside
| Overweight |
10 Nov ‘22
2 years ago |
|
1629
Bioventus
BVS
$486M
|
DR
Drew Ranieri
| $7.27 | $5 |
31%
downside
| Overweight |
10 Nov ‘22
2 years ago |
|
1630
ProKidney
PROK
$381M
|
VP
Vikram Purohit
| $2.82 | $13 |
361%
upside
| Equal-Weight |
10 Nov ‘22
2 years ago |
|
1631
Sweetgreen
SG
$1.02B
|
JG
John Glass
| $8.66 | $21 |
142%
upside
| Overweight |
9 Nov ‘22
2 years ago |
|
1632
Viasat
VSAT
$4.14B
|
LP
Landon Park
| $30.87 | $36 |
17%
upside
| Equal-Weight |
8 Nov ‘22
2 years ago |
|
1633
Harley-Davidson
HOG
$3.73B
|
MC
Michael Cyprys
| $30.70 | $43 |
40%
upside
| Equal-Weight |
7 Nov ‘22
2 years ago |
|
1634
DraftKings
DKNG
$22.5B
|
EY
Ed Young
| $45.25 | $28 |
38%
downside
| Overweight |
7 Nov ‘22
2 years ago |
|
1635
Akero Therapeutics
AKRO
$3.53B
|
MH
Matthew Harrison
| $44.16 | $40 |
9%
downside
| Equal-Weight |
7 Nov ‘22
2 years ago |
|
1636
Vir Biotechnology
VIR
$725M
|
AG
Andrew Galler
| $5.22 | $18 |
245%
upside
| Underweight |
4 Nov ‘22
2 years ago |
|
1637
Sprout Social
SPT
$827M
|
SZ
Stan Zlotsky
| $14.06 | $60 |
327%
upside
| Equal-Weight |
4 Nov ‘22
2 years ago |
|
1638
Schrodinger
SDGR
$1.37B
|
VP
Vikram Purohit
| $18.57 | $38 |
105%
upside
| Equal-Weight |
4 Nov ‘22
2 years ago |
|
1639
Portillo's
PTLO
$441M
|
JG
John Glass
| $6.13 | $25 |
308%
upside
| Equal-Weight |
4 Nov ‘22
2 years ago |
|
1640
Itron
ITRI
$5.52B
|
CL
Connor Lynagh
| $120.78 | $50 |
59%
downside
| Equal-Weight |
4 Nov ‘22
2 years ago |
|
1641
Insulet
PODD
$24B
|
DL
David Lewis
| $340.27 | $300 |
12%
downside
| Equal-Weight |
4 Nov ‘22
2 years ago |
|
1642
Amgen
AMGN
$151B
|
MH
Matthew Harrison
| $280.67 | $282 |
0%
upside
| Overweight |
4 Nov ‘22
2 years ago |
|
1643
Trimble
TRMB
$19.6B
|
JF
James Faucette
| $82.51 | $63 |
24%
downside
| Equal-Weight |
3 Nov ‘22
2 years ago |
|
1644
NNN REIT
NNN
$8.13B
|
RK
Ronald Kamdem
| $43.06 | $46 |
7%
upside
| Equal-Weight |
2 Nov ‘22
2 years ago |
|
1645
Exelixis
EXEL
$10.4B
|
JH
Jeffrey Hung
| $38.46 | $22 |
43%
downside
| Equal-Weight |
2 Nov ‘22
2 years ago |
|
1646
Agree Realty
ADC
$8.11B
|
RK
Ronald Kamdem
| $73.27 | $73 |
0%
downside
| Overweight |
2 Nov ‘22
2 years ago |
|
1647
AGCO
AGCO
$8.14B
|
CY
Courtney Yakavonis
| $109.15 | $119 |
9%
upside
| Equal-Weight |
2 Nov ‘22
2 years ago |
|
1648
Gogo Inc
GOGO
$1.39B
|
LP
Landon Park
| $10.38 | $15 |
45%
upside
| Equal-Weight |
1 Nov ‘22
2 years ago |
|
1649
Lazard
LAZ
$5.35B
|
MG
Manan Gosalia
| $56.71 | $29 |
49%
downside
| Underweight |
31 Oct ‘22
2 years ago |
|
1650
Humana
HUM
$33.5B
|
RG
Ricky Goldwasser
| $278.92 | $620 |
122%
upside
| Overweight |
31 Oct ‘22
2 years ago |
|